Muscat: The National Center for Oncology at the Royal Hospital provides the latest treatments in oncology through its various departments under the supervision of a specialized medical staff, and provides integrated care for cancer patients in the Sultanate of Oman, according to which it has obtained international accreditations.
The center witnessed a quantitative expansion and qualitative development in the use of treatments through many clinics, including specialized clinics for children in oncology and hematology, a joint clinic for treating breast cancer, a clinic for treating colorectal cancer, a clinic for treating the urinary system, a joint specialized clinic for treating ear, nose and throat cancers at Al Nahda Hospital, and a gynecology clinic in radiation. A lung cancer clinic and another for hematology.
The center provides its specialized services according to the latest treatments available in genetic or cellular oncology, and targeted and immunotherapy treatments, including immunotherapy to treat children with neuroblastoma, which is one of the most common malignant tumors in children under the age of 5 years.
This treatment is one of the advanced treatments that raises recovery rates to more than 40 percent above the internationally approved cure rates. Among the most prominent positive indicators is the center’s ability to receive a newly diagnosed patient on the same day from all governorates of the Sultanate of Oman, as the average life expectancy of patients has reached advanced stages in some types of cancer thanks to the treatment and modern medical technologies available.
The National Center for Oncology at the Royal Hospital is an integrated center providing all types of treatment for cancerous tumors by providing chemotherapy and immunotherapy directed through the latest scientific findings of modern genetic medicines.
Statistics issued by the center indicate that the total number of visitors to the center during the past year until August amounted to 140,373 patients, distributed among the center’s various departments. The total number of visitors during this period to the clinical hematology department reached 20,760, and in the adult oncology department it reached 13,157. In the Department of Pediatric Hematology, it reached 41,657, and in the Department of Radiotherapy and Chemotherapy, 25,760.
The Center’s Pediatric Hematology and Oncology Department receives children under the age of 13, and thus it is the only department in the Sultanate of Oman that specializes in treating solid somatic tumors (children’s category), which are musculoskeletal tumors, abdominal tumors, lymphomas, and nervous system tumors.
more recommended stories
Imam Jabir bin Zaid Waqf Foundation Unveils Campaign to Promote Gheras Endowment Investment Fund
Muscat: The marketing campaign for Gheras.
Bank Nizwa Empowers Individual Business Owners with Sharia-Compliant Commercial Finance
Muscat: Recognizing the value and potential.
OCCI’s Suhar Investment Forum to explore multi billion investment opportunities in Al Batinah North
December: The Suhar Investment Forum 2024,.
ahlibank Discusses Importance of Diversification in Wealth Management Conference
Muscat: Demonstrating a commitment to thought-leadership and.
National Finance Renews Partnership with SignBook Oman to provide Instant Translation Services for Persons with Hearing Disabilities
Muscat: Establishing a benchmark of excellence.
National Finance Reaffirms Partnership with Injaz Oman to Further Drive Youth Development
Muscat: Recognising the pivotal role that.
ITOCHU Corporation commemorates its 50th anniversary in Oman
ITOCHU Corporation commemorates its 50th anniversary.
Outstanding Students Honoured with OMIFCO Scientific Excellence Award 2022/2023
South Al Sharqiyah Governorate celebrates OMIFCO.
Oman participates in 39th Ministerial Meeting of COMCEC
Istanbul: The Sultanate of Oman, represented.
1st Muscat Dialogue Sessions Begin
Muscat: The first Muscat Dialogue sessions.